MedChem and CADD 2017 Market Analysis and Reports | USA Conference Series

Market Analysis - MedChem And CADD 2017, USA

chemistry

 

Importance & Scope:

Significance of recent trends reviews the state of the art and aims to determine the significance of technology and market trends in medicinal chemistry for advancing productivity in drug discovery. One in particular, fragment-based drug design, stands out as promising major improvements in research productivity. After analysis it proves that medicinal chemistry-related approaches and methodologies that drug discovery organizations employ in an effort to increase productivity in early drug discovery. Its key topics considered include structure-based drug design, fragment-based drug design, natural products-based drug design, diversity-oriented synthesis, and chemogenomics. Various ways of computer-aided drug design are also considered, as the complexity and limitations of drug discovery programs that are based on biochemical screens of large compound collections have been major factors in stimulating the growth of this modality.
 

Why Dallas, Texas?

Texas pharmaceutical giant maintained a robust lead over drug makers in our annual ranking of the largest Bio-Pharma companies in the United States of America.

However, the pharmaceutical market is still dominated by a few very large companies that control the import/distribution, retail and manufacturing sectors. While these companies have played an important role in the pharmaceutical sector’s development in Georgia, their market dominance leads to high mark-up for medicines which explain the high expenditures on pharmaceuticals. The mark-up for medicines in Georgia is far above the average mark-up for medicines than in European countries.
 

Conference Highlights:

Frontiers in Chemistry
Pharmaceutical Chemistry
Novel Drug Discovery & Drug Delivery
Computer Aided Drug Designing-CADD
Computational Chemistry
Targeted Drug Delivery (Smart Drug Delivery)
New Trends in Pharmacology & Drug Development
Cancer Studies: Drug Delivery and Chemistry
Drugs for Emerging Diseases
Neurodegenerative Diseases
Chem-Virology (Zika Virus)
Chemical Biology
ChemBioChem-Antimicrobials and Infectious Agents & Diseases
Organic and Medicinal Chemistry
Carbon Chemistry
Hyphenated Chromatographic Techniques
 

Why to attend???

Meet your target market with members from around the world focused on learning about advertising and marketing, this is your single best opportunity to reach the largest assemblage of participants from all over the world. Conduct demonstrations, distribute information, meet with current and potential customers, make a splash with a new product line, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in advertising and marketing fields are hallmarks of this conference.
 

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://medicinalchemistry.pharmaceuticalconferences.com/sponsors.php
 

Major Marketing Associations around the Globe

·         American Association for Clinical Chemistry

·         American Chemical Society

·         American Institute of Chemists (AIC)

·         American Society of Brewing Chemists

·         American Society for Mass Spectrometry

·         Royal Society of Chemistry (RSC)

·         Swedish Chemical Society

·         New Swiss Chemical Society

·         Syngenta, Hyderabad Area, India

·         DCTG, Beijing City, China

·         Oceanus Group Ltd, Singapore
 

Major Marketing Associations in USA

·         American Association for Clinical Chemistry

·         American Chemical Society

·         American Institute of Chemists(AIC)

·         American Society of Brewing Chemists

·         American Society for Mass Spectrometry

 

Statistical Analysis of Associations


Associations & Societies


Figure 1: Statistical Analysis
 

Target Audience:

Directors/Managers & Business Intelligence Experts, Departmental Managers, Vice Presidents/Directors & Brand Manufacturers/ Marketers of Consumer Products. Retailers, Marketing, Advertising and Promotion Agency Executives, Solution Providers (Digital and Mobile Technology, P-O-P Design, Retail Design, and Retail Execution), Professors and Students from academia in the study of marketing and advertising filed.
 

Top Universities in Texas:

Texas Tech University Health Sciences Center
The University of Texas at Austin
Texas A&M University
University of Houston
University of Texas at San Antonio
Texas State University

 

Universities

Figure2: Top Universities in Dallas & Texas

 

USA Pharmaceutical Companies Associated with Advertising and Marketing Activities

The United States is the largest market for pharmaceuticals (including biopharmaceuticals), accounting for around 35 percent of the global market, and is the world leader in biopharmaceutical research and development (R&D). According to the Pharmaceutical Research and Manufacturers Association (PhRMA), U.S. firms conduct the majority of the world's research and development in pharmaceuticals and hold the intellectual property rights on most new medicines. The biopharmaceutical pipeline also has over 7,000 new medicines currently in development around the world with approximately 3,500 compounds currently being studied in the United States - more than any other region around the world. The National Science Foundation reports that the U.S. biopharmaceutical sector accounts for the largest single share of all U.S. business research and development (R&D) investment, representing 23.4 percent of all domestic R&D funded by U.S. business in 2013.


More than 854,000 people work in the biopharmaceutical industry in the United States across a broad range of occupations, such as scientific research, technical support and manufacturing. Directly and indirectly, the industry supports a total of 4.4 million jobs across the United States and added an estimated $1.2 trillion in economic output in 2014, representing 3.8 percent of total U.S. output. The biopharmaceutical industry provides average salaries well above the average for all U.S. workers, and requires a highly-skilled and educated workforce from the administrative level up to and including Ph.D. scientists.  

Fast growing segments of the pharmaceutical market include biologics, generics and over-the-counter (OTC) drugs. Biologics now account for over a third of all new drugs in clinical trials or awaiting FDA approval. U.S. generic drug sales reached an estimated $70 billion in 2015, representing a quarter of the global market, due to a large number of drugs going off-patent and healthcare reforms favouring generics.  OTC market growth will be driven by a growing aging population, consumer trends towards self-medication, and the conversion of drugs from prescription to non-prescription or OTC status.

The United States has one of the world’s most supportive domestic environments for the development and commercialization of pharmaceuticals with minimal market barriers. Its strengths include an intellectual property system that rewards innovation through patent and data protection, a science-based regulatory system that is considered the most rigorous in the world, the world’s largest scientific research base fostered by academic institutions and decades of government research funding, and robust capital markets. The United States attracts the majority of global venture capital investments in start-up biopharmaceutical enterprises.

In addition, the United States is the world’s largest free-pricing market for pharmaceuticals and has high per capita incomes, a large elderly population, and high rates of chronic diseases and drug consumption. All of these factors ensure that the United States will remain the world’s most important pharmaceutical market for the foreseeable future with healthy growth expected across all product sectors.


USA Pharmaceutical Organizations

Figure 3:  Companies Associated with Advertising and Marketing
 

Glance at Market of Advertising and Marketing:

It has estimated that in the field of medicinal chemistry more than $79 million in research funding has spent since 2008. A complete overview of drug designing process has come up with some crucial details that from year 2008 to 2013 the market has a growth with $ 198 Billion and in further this rate may increases to $236 Billion from year 2014 to 2019. Special emphasis is given on computational approaches for drug discovery along with salient features and applications of the software’s used in denovo drug designing.

In the future year of 2020, the revenue budget of drug designing or drug production reveals that the large drug companies are facing the expiry of patents on their best sellers. At the same time they are having trouble inventing new medicines, and this means that the drug industry’s sales may at best tread water and could face some steep drops. The point of market analysis is to see what happens after the immediate patent expirations, like the loss of Lipitor from highly reputed companies, to see what happens next.